Awakn Life Sciences (FRA:954) FCF Margin % : -13,233.33% (As of Oct. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Awakn Life Sciences's Free Cash Flow for the three months ended in Oct. 2024 was €-0.40 Mil. Awakn Life Sciences's Revenue for the three months ended in Oct. 2024 was €0.00 Mil. Therefore, Awakn Life Sciences's FCF Margin % for the quarter that ended in Oct. 2024 was -13,233.33%.

As of today, Awakn Life Sciences's current FCF Yield % is 76.25%.

The historical rank and industry rank for Awakn Life Sciences's FCF Margin % or its related term are showing as below:

FRA:954' s FCF Margin % Range Over the Past 10 Years
Min: -4361.44 Med: -3108.31 Max: 5323.08
Current: 5323.08

During the past 4 years, the highest FCF Margin % of Awakn Life Sciences was 5323.08%. The lowest was -4361.44%. And the median was -3108.31%.

FRA:954's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -139.165 vs FRA:954: 5323.08

Awakn Life Sciences FCF Margin % Historical Data

The historical data trend for Awakn Life Sciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences FCF Margin % Chart

Awakn Life Sciences Annual Data

Trend

Jan21

Jan22

Jan23

Jan24

FCF Margin %

-4,369.09

-1,871.19

Awakn Life Sciences Quarterly Data
	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
FCF Margin %	Get a 7-Day Free Trial											-14,155.00	18,746.67	-2,435.71	28.57	-13,233.33

Competitive Comparison of Awakn Life Sciences's FCF Margin %

For the Biotechnology subindustry, Awakn Life Sciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Awakn Life Sciences's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Awakn Life Sciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Awakn Life Sciences's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Awakn Life Sciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Awakn Life Sciences's FCF Margin for the fiscal year that ended in Jan. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Jan. 2024 )	/	Revenue (A: Jan. 2024 )
	=	-1.104	/	0.059
	=	-1,871.19 %

Awakn Life Sciences's FCF Margin for the quarter that ended in Oct. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Oct. 2024 )	/	Revenue (Q: Oct. 2024 )
	=	-0.397	/	0.003
	=	-13,233.33 %

Awakn Life Sciences FCF Margin % Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Awakn Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (FRA:954) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2

Website

https://www.awaknlifesciences.com

Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling it to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences Headlines

No Headlines